BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/28/2014 9:18:00 AM | Browse: 1207 | Download: 1232
 |
Received |
|
2013-11-10 15:28 |
|
Peer-Review Started |
|
2013-11-10 19:13 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-02-20 09:17 |
|
Revised |
|
2014-02-21 23:09 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-03-18 14:58 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-03-18 15:19 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
2014-03-31 16:22 |
|
Typeset the Manuscript |
|
2014-05-14 13:30 |
|
Publish the Manuscript Online |
|
2014-05-16 12:07 |
| Category |
Critical Care Medicine |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Pneumomediastinum after acute lymphoblastic leukemia and chemotherapy?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Alain Cruz-Portelles |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Alain Cruz-Portelles, MD, Critical Care Medicine Department, V I Lenin University General Hospital, Lenin Ave., No. 2, Holguin 80100, Cuba. acruz2014@gmx.es |
| Key Words |
Acute lymphoblastic leukemia; Pneumomediastinum; Pneumorachis; Chemotherapy; Case report |
| Core Tip |
In the article presented by Showkat et al, the authors reported a 14-year-old male with acute lymphoblastic leukemia (ALL) under chemotherapy who developed pneumomediastinum, pneumorachis and subcutaneous emphysema, apparently caused by ALL or chemotherapy in the author’s opinion, and eventually died. |
| Publish Date |
2014-05-16 12:07 |
| Citation |
Cruz-Portelles A. Pneumomediastinum after acute lymphoblastic leukemia and chemotherapy? World J Clin Cases 2014; 2(5): 170-171 |
| URL |
http://www.wjgnet.com/2307-8960/full/v2/i5/170.htm |
| DOI |
http://dx.doi.org/10.12998/wjcc.v2.i5.170 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
